The page is the record's research on the issuer — no analyst, no rating, no view. # LEXICON PHARMACEUTICALS, INC. (NASDAQ: LXRX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is LEXICON PHARMACEUTICALS, INC., listed on NASDAQ under ticker LXRX, with ISIN US5288723027. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 68 filings on 25 filing days in the twelve months to 2026-11-08. The median gap between filing days is 3.5 days. The latest filing was made on 2026-11-05, 3 days before the record date, and is a results filing. On NASDAQ the median cadence gap is 6.0 days, the median filings are 52, and the median latency is 5.0 days across 4359 issuers. In the sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filings are 63.0, and the median latency is 4.0 days across 526 issuers. By type the record holds 38 directors' dealings, 11 regulatory filings, 9 results, 4 corporate news, 3 AGM or EGM filings, and 3 prospectuses. ## Auditor The auditor of record is Ernst & Young LLP, located in Houston, Texas. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001062822.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/LXRX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1062822/000106282226000050/lxrx-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/LXRX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/LXRX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp